aripiprazole has been researched along with Adverse Drug Event in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (6.06) | 29.6817 |
| 2010's | 17 (51.52) | 24.3611 |
| 2020's | 14 (42.42) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Blum, AW; Grant, JE; Jacobson, K | 1 |
| Bhat, V; Demchenko, I; Espinola, CW; Frey, BN; Ho, K; Kennedy, SH; Khoo, Y; Lam, RW; Lou, W; Milev, RV; Parikh, SV; Parmar, R; Ravindran, AV; Rotzinger, S | 1 |
| Byeon, SJ; Chung, SJ; Oh, S | 1 |
| Ahmed, NJ; Alahmari, A; Almalki, ZS; Alshehri, AM | 1 |
| Guzek, K; Najbar, I; Rożnowska, A; Sadakierska-Chudy, A; Stelmach, A | 1 |
| Anand, G; Lee, J; Shepperd, R; Smith, M | 1 |
| Jha, MK; Mathew, SJ | 1 |
| Birur, B; Burk, BG; DiGiacomo, T; Polancich, S; Pruett, BS; Sivaraman, S | 1 |
| Bastiaansen, D; de Kroon, MMJ; de Winter, BCM; Dierckx, B; Hermans, RA; Hillegers, MHJ; Kloosterboer, SM; Koch, BCP; Kouijzer, MEJ; Nasserinejad, K; Reichart, CG; Sassen, SDT; van Altena, D; van Schaik, RHN | 1 |
| Benson, EA; Callaghan, JT; Desta, Z; Dexter, PR; Eadon, MT; Fulton, CR; Gufford, BT; Gupta, SK; Haas, DM; Holmes, AM; Kreutz, RP; Levy, KD; Pierson, RC; Pratt, VM; Rosenman, MB; Shugg, T; Skaar, TC; Tillman, EM; Vuppalanchi, R; Zang, Y; Zhang, P | 1 |
| Abdijadid, S; Kiai, N; Meza, C; Salam, MT; Torrico, T | 1 |
| Cohen, D; Coustals, N; Ménard, ML | 1 |
| Ivanov, I; Nicol, GE | 1 |
| Nakamura, T; Sasayama, D; Takahashi, K; Washizuka, S | 1 |
| Baldelli, S; Bernardi, FF; Bernardini, R; Bravaccio, C; Capuano, A; Cattaneo, D; Cheli, S; Clementi, E; Molteni, M; Pozzi, M; Radice, S; Rafaniello, C; Rossi, F; Sessa, M | 1 |
| Chaudhary, AM; Felin, T; Naveed, S | 1 |
| Flavin, KS; Newcomer, JW; Nicol, GE; Patterson, BW; Schechtman, KB; Schweiger, JA; Yingling, MD | 1 |
| Downing, L; Kim, DD; Procyshyn, RM`; Tibbo, P | 1 |
| Ameis, SH; Cole, L; Corbett-Dick, P; Correll, CU | 1 |
| Ghanizadeh, A; Jaafari, N; Tordjman, S | 1 |
| Hashiguchi, M; Imai, S; Maruyama, J; Mochizuki, M; Shimizu, M; Uehara, K | 1 |
| Bruhn, CH; Fink-Jensen, A; Jakobsen, KD; Nielsen, J; Pagsberg, AK | 1 |
| Akpek, M; Avcil, M; Kantekin, B; Kapçı, M; Yavaşoğlu, I | 1 |
| Bruhn, CH; Hashemi, N; Nielsen, J; Polcwiartek, C; Rosenzweig, M; Vang, T | 1 |
| Khan, A; Kneale, B | 1 |
| Carleton, BC; Etminan, M; Guo, M; Procyshyn, RM; Samii, A; Sodhi, M | 1 |
| Breder, CD; Carson, WH; Marcus, R; McQuade, R; Porsteinsson, AP; Streim, JE; Swanink, R | 1 |
| Appel, DI; Markowitz, JS; Peterson, YK; Wang, Z; Zhu, HJ | 1 |
| Pomeraniec, F; Primeau, M; Wallace, DM | 1 |
| Carson, WH; Fleischhacker, WW; Forbes, RA; Jin, N; Johnson, BR; Kane, JM; McQuade, RD; Perry, PP; Sanchez, R | 1 |
| Berman, RM; Carson, WH; Factor, SA; Friedman, JH; Goetz, CG; Marcus, RN; Ondo, WG; Wojcieszek, J | 1 |
6 review(s) available for aripiprazole and Adverse Drug Event
| Article | Year |
|---|---|
Antipsychotic drug-aripiprazole against schizophrenia, its therapeutic and metabolic effects associated with gene polymorphisms.
Topics: Antipsychotic Agents; Aripiprazole; Dopamine; Drug-Related Side Effects and Adverse Reactions; Humans; Polymorphism, Genetic; Schizophrenia | 2023 |
Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic Landscape.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Depression; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Drug-Related Side Effects and Adverse Reactions; Humans; United States | 2023 |
Aripiprazole in Children and Adolescents.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Drug-Related Side Effects and Adverse Reactions; Humans; Off-Label Use; Schizophrenia; Tourette Syndrome; Weight Gain | 2021 |
Aripiprazole-Induced Neutropenia: Case Report and Literature Review.
Topics: Antipsychotic Agents; Aripiprazole; Child; Drug-Related Side Effects and Adverse Reactions; Humans; Male; Neutropenia | 2018 |
Aripiprazole for treating irritability in children & adolescents with autism: A systematic review.
Topics: Adolescent; Aripiprazole; Autistic Disorder; Child; Drug-Related Side Effects and Adverse Reactions; Humans; Randomized Controlled Trials as Topic | 2015 |
Diabetic ketoacidosis in patients exposed to antipsychotics: a systematic literature review and analysis of Danish adverse drug event reports.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Glucose; Clozapine; Denmark; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Olanzapine; Risk Factors; Risperidone; Young Adult | 2016 |
4 trial(s) available for aripiprazole and Adverse Drug Event
| Article | Year |
|---|---|
The INGENIOUS trial: Impact of pharmacogenetic testing on adverse events in a pragmatic clinical trial.
Topics: Aripiprazole; Drug-Related Side Effects and Adverse Reactions; Humans; Norepinephrine; Pharmacogenomic Testing; Serotonin | 2023 |
Metabolic Effects of Antipsychotics on Adiposity and Insulin Sensitivity in Youths: A Randomized Clinical Trial.
Topics: Abdominal Fat; Absorptiometry, Photon; Adolescent; Antipsychotic Agents; Aripiprazole; Child; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Insulin Resistance; Intention to Treat Analysis; Male; Mental Disorders; Olanzapine; Problem Behavior; Risperidone; Treatment Outcome | 2018 |
A randomized, double-blind, placebo-controlled study of aripiprazole for the treatment of psychosis in nursing home patients with Alzheimer disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Aripiprazole; Behavioral Symptoms; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Nursing Homes; Piperazines; Psychotic Disorders; Quinolones; United States | 2008 |
Aripiprazole intramuscular depot as maintenance treatment in patients with schizophrenia: a 52-week, multicenter, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Delayed-Action Preparations; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Injections, Intramuscular; Kaplan-Meier Estimate; Male; Middle Aged; Piperazines; Proportional Hazards Models; Quinolones; Schizophrenia; Secondary Prevention | 2012 |
23 other study(ies) available for aripiprazole and Adverse Drug Event
| Article | Year |
|---|---|
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Legal settlements and the reporting of adverse drug events: Insights from the aripiprazole products liability litigation.
Topics: Aripiprazole; Drug-Related Side Effects and Adverse Reactions; Humans; Liability, Legal; United States | 2022 |
Pretreatment anxious depression as a predictor of side effect frequency and severity in escitalopram and aripiprazole adjunctive therapy.
Topics: Aripiprazole; Depression; Depressive Disorder, Major; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Escitalopram; Humans; Treatment Outcome | 2022 |
Characteristics of adverse reactions among antipsychotic drugs using the Korean Adverse Event Reporting System database from 2010 to 2019.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Clozapine; Drug-Related Side Effects and Adverse Reactions; Haloperidol; Humans; Olanzapine; Paliperidone Palmitate; Quetiapine Fumarate; Retrospective Studies; Risperidone; Schizophrenia | 2022 |
Drug-induced weight gain in the last 10 years: a descriptive study.
Topics: Adalimumab; Adverse Drug Reaction Reporting Systems; Aripiprazole; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Etanercept; Humans; Prednisone; Pregabalin; Retrospective Studies; Risperidone; United States; Weight Gain | 2022 |
Recognising side effects of antipsychotics in children with intellectual disabilities.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Child; Drug-Related Side Effects and Adverse Reactions; Humans; Intellectual Disability; Risperidone | 2023 |
Antipsychotics and obsessive-compulsive disorder/obsessive-compulsive symptoms: A pharmacovigilance study of the FDA adverse event reporting system.
Topics: Antipsychotic Agents; Aripiprazole; Drug-Related Side Effects and Adverse Reactions; Humans; Obsessive-Compulsive Disorder; Pharmacovigilance; Prospective Studies | 2023 |
Towards precision dosing of aripiprazole in children and adolescents with autism spectrum disorder: Linking blood levels to weight gain and effectiveness.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Body Mass Index; Child; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Weight Gain | 2023 |
Suspected Aripiprazole-induced neutropenia in a geriatric patient: a case report.
Topics: Aged; Antipsychotic Agents; Aripiprazole; Drug-Related Side Effects and Adverse Reactions; Humans; Male; Mental Disorders; Neutropenia | 2020 |
Getting to Precision Psychopharmacology in Child Psychiatry: The Value of Adverse Treatment Effects.
Topics: Antipsychotic Agents; Aripiprazole; Child; Child Psychiatry; Drug-Related Side Effects and Adverse Reactions; Humans; Obesity; Precision Medicine; Psychopharmacology; Risperidone | 2021 |
Orthostatic Hypotension: Uncommon Side Effect of Aripiprazole.
Topics: Aripiprazole; Blood Pressure; Drug-Related Side Effects and Adverse Reactions; Humans; Hypotension, Orthostatic | 2021 |
The predictive value of ABCB1, ABCG2, CYP3A4/5 and CYP2D6 polymorphisms for risperidone and aripiprazole plasma concentrations and the occurrence of adverse drug reactions.
Topics: Adolescent; Aripiprazole; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; Child; Child, Preschool; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Drug-Related Side Effects and Adverse Reactions; Female; Genotype; Humans; Male; Neoplasm Proteins; Olanzapine; Pediatrics; Polymorphism, Genetic; Quetiapine Fumarate; Risperidone; Schizophrenia; Young Adult | 2018 |
Management of sexual adverse effects induced by atypical antipsychotic medication
Topics: Adult; Antipsychotic Agents; Aripiprazole; Drug Substitution; Drug-Related Side Effects and Adverse Reactions; Humans; Male; Risperidone; Schizophrenia; Sexual Dysfunction, Physiological | 2019 |
Decision making and antipsychotic medication treatment for youth with autism spectrum disorders: applying guidelines in the real world.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Child; Child Development Disorders, Pervasive; Child, Preschool; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Humans; Piperazines; Practice Guidelines as Topic; Psychiatric Status Rating Scales; Quinolones; Risk Assessment; Risperidone | 2013 |
Factors Affecting the Timing of Signal Detection of Adverse Drug Reactions.
Topics: Adverse Drug Reaction Reporting Systems; Aripiprazole; Chemical and Drug Induced Liver Injury; Data Mining; Databases, Factual; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Exenatide; Humans; Hypercalcemia; Ketolides; Pancreatitis; Peptides; Rhabdomyolysis; Rosuvastatin Calcium; Suicide; Teriparatide; Time Factors; United States; United States Food and Drug Administration; Varenicline; Venoms | 2015 |
Neurological, Metabolic, and Psychiatric Adverse Events in Children and Adolescents Treated With Aripiprazole.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Child; Child, Preschool; Databases, Factual; Denmark; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Neurodevelopmental Disorders; Obsessive-Compulsive Disorder; Psychotic Disorders; Schizophrenia; Tourette Syndrome | 2016 |
Simultaneous Use of Intravenous Lipid Emulsion and Plasma Exchange Therapies in Multiple Drug Toxicity.
Topics: Amisulpride; Antihypertensive Agents; Antipsychotic Agents; Aripiprazole; Diazepam; Drug-Related Side Effects and Adverse Reactions; Fat Emulsions, Intravenous; Female; Humans; Hypnotics and Sedatives; Hypotension; Middle Aged; Paliperidone Palmitate; Plasma Exchange; Suicide, Attempted; Sulpiride; Treatment Outcome; Turkey; Valsartan | 2016 |
Life threatening torsades de pointes due to abiraterone-induced hypokaelemia in a patient with metastatic prostate cancer.
Topics: Aged; Antipsychotic Agents; Aripiprazole; Drug-Related Side Effects and Adverse Reactions; Humans; Long QT Syndrome; Male; Prostatic Neoplasms; Torsades de Pointes | 2016 |
Risk of Gambling Disorder and Impulse Control Disorder With Aripiprazole, Pramipexole, and Ropinirole: A Pharmacoepidemiologic Study.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzothiazoles; Canada; Case-Control Studies; Cohort Studies; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Drug-Related Side Effects and Adverse Reactions; Female; Gambling; Humans; Indoles; Male; Middle Aged; Pramipexole | 2017 |
Identification of selected therapeutic agents as inhibitors of carboxylesterase 1: potential sources of metabolic drug interactions.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Carboxylic Ester Hydrolases; Central Nervous System Stimulants; Cluster Analysis; Drug Evaluation, Preclinical; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Humans; Hydrolysis; Inactivation, Metabolic; Male; Methylphenidate; Mice; Models, Molecular; Piperazines; Quinolones | 2010 |
Serotonin toxicity in aripiprazole augmentation.
Topics: Antipsychotic Agents; Aripiprazole; Citalopram; Cyproheptadine; Drug Synergism; Drug-Related Side Effects and Adverse Reactions; Humans; Male; Middle Aged; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists | 2012 |
Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Drug Tolerance; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Parkinson Disease; Pilot Projects; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quinolones; Severity of Illness Index; Time Factors | 2006 |